Numan Raises $20M in Debt; Closes $60.1M Series B Round
Summary
The round was led by White Star Capital, with participation from Novator, VNV Global, and Anthemis Exponential. The new funding coincides with launch of blood testing proposition in the UK, as Numan looks to double headcount in 2022. The company also plans to use the funding to launch new therapeutic areas in men’s health and expand internationally. The subscription service for healthcare treatments enables members to receive medication and other products to home rather than having a pharmacy trip. All patients have ongoing access to a team of clinicians who are on hand to help and inform them to make the best decisions for their health.
Funding
Review available funding amount, funding date, investors, and linked company information related to Numan Raises $20M in Debt; Closes $60.1M Series B Round in the interactive ISVWorld profile.